K. Tate

Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice.

I. Weissman, A. Logan, D. Kohn, 2019, Blood.

Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.

R. Negrin, E. Meyer, R. Armstrong, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

Mark M. Davis, N. Bhatia, M. Roncarolo, 2021, Science Translational Medicine.

Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.

H. Kohrt, Kenneth D. Gibbs, M. Florek, 2012, Blood.

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

L. Tian, D. Miklos, R. Negrin, 2015 .

Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients.

D. Miklos, B. Sahaf, Sai-Wen Tang, 2019, JCI insight.

A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease

D. Miklos, B. Sahaf, R. Negrin, 2016 .

Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation.

D. Miklos, R. Negrin, L. Muffly, 2018, Blood advances.

Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface

Y. Chien, M. Davis, H. Mcconnell, 1996, The Journal of experimental medicine.

Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients.

D. Miklos, B. Sahaf, Sai-Wen Tang, 2019, JCI insight.

A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products

M. Roncarolo, R. Bacchetta, Yohei Sato, 2023, Molecular therapy. Methods & clinical development.

Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.

E. Meyer, R. Armstrong, R. Lowsky, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.